Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder

Bipolar Spectrum Disorder Clinical Trial

Status Completed

Clinical Trial Summary

The objective of this study is to compare the safety and effectiveness of Risperidone, Olanzapine, and Quetiapine in the treatment of mania in children and adolescents with Bipolar disorder over 8 weeks and then over an extension phase. This is an exploratory, open-label study, which seeks to determine if there is evidence for efficacy. The results of this study will be used to generate hypotheses for a larger study.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Bipolar Spectrum Disorder

Clinical Trial Details

NCT number	NCT00182013
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	June 2001

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04859647` - Client-led Online Therapy for People Diagnosed With Bipolar Disorder	N/A
	Withdrawn	`NCT01932541` - Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old	Phase 4